Table 2.
Bacterial infections in 135 COVID-19 patients. Anatomic site and microorganism
| N (%) | |
|---|---|
| Site of infection | |
| Lung | 43 (31.8) |
| Community-acquiredy/superinfection | 22/43 (51.2) |
| Nosocomial | 21/43 (48.8) |
| Bacteremia | 43 (31.9) |
| Catheter related | 29/43 (67.4) |
| Primary | 14/43 (32.6) |
| Urinary tract | 44 (32.6) |
| Intra-abdominal | 9 (6.7) |
| Skin and soft tissue | 9 (6.7) |
| Others* | 8 (5.9) |
| Microorganism | |
| Gram-positive cocci | 73 (54.1) |
| MRSA | 11 (8.2) |
| MSSA | 2 (1.5) |
| CNS | 32 (23.7) |
| Enterococci | 34 (25.2) |
| Streptococci | 16 (11.9) |
| Enterobacterales | 40 (29.6) |
| E. Coli | 30 (22.2) |
| Klebsiella spp. | 16 (11.9) |
| Enterobacter spp. | 3 (2.2) |
| Others | 2 (1.5) |
| Non-fermentative gram-negative | 13 (9.6) |
| P. aeruginosa | 12 (8.9) |
| Stenotrophomonas maltophilia | 4 (3) |
| Acinetobacter spp. | 1 (1) |
| Achromobacter spp. | 1 (1) |
| Anaerobic bacteria | 9 (6.7) |
| Clostridium difficile | 4 (3) |
MRSA Methicillin-resistant Staphylococcus aureus, MSSA Methicillin-sensitive Staphylococcus aureus, CNS Coagulase-Negative Staphylococci
*Included meningitis (2 cases), endocarditis (2 cases), otorhinolaryngology site (2 cases), tuberculosis (1 case), or septic shock from unknown foci (1 case)